Navigation Links
CryoCath to Hold Third Quarter 2008 Conference Call and Webcast
Date:7/30/2008

http://www.cryocath.com

Toronto Stock Exchange Symbol: CYT

MONTREAL, July 30 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will hold a conference call to discuss its third quarter 2008 financial results at 9:00 a.m. (Eastern Time) on Tuesday, August 5, 2008. The call will be hosted by Mr. Jan Keltjens, President and CEO and Mrs. Ginette Gagne, CFO. The Company will report its results in a press release to be issued at 7:00 a.m on Tuesday, August 5.

DATE: Tuesday, August 5, 2008

TIME: 9:00 a.m., Eastern Time

DIAL IN NUMBER: 416-644-3427 or 1-866-250-4892

TAPED REPLAY: 416-640-1917 or 1-877-289-8525

REFERENCE NUMBER: 21279395 followed by the number sign

WEBCAST: A live audio webcast of the call will be available

at http://www.cryocath.com. Webcast attendees are welcome

to listen to the conference in real-time or

on-demand at their convenience. The webcast will be

archived for 365 days. Please connect to this

website at least 15 minutes prior to the conference

call to ensure adequate time for any software

download that may be needed to hear the webcast.

A question and answer session will follow, at which time the operator will direct participants as to the correct procedure for submitting questions.

About CryoCath

CryoCath - http://www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at http://www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.


'/>"/>
SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoCath Appoints Vice President, Europe
2. CryoCath Presents at Prestigious Heart Rhythm Society Meeting
3. CryoCath Announces Fiscal 2008 Second Quarter Results
4. CryoCath to Hold Second Quarter 2008 Conference Call and Webcast
5. CryoCath Reports Data Presented at the 74th Annual Meeting of the German Cardiac Society
6. CryoCath Introduces Arctic Front in Australia
7. CryoCath Appoints New Chief Financial Officer
8. CryoCath Technologies notice of annual meeting
9. CryoCath Announces Fiscal 2008 First Quarter Results
10. CryoCath Provides Update on Patent Infringement Lawsuit
11. CryoCath to Hold First Quarter 2008 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... 26, 2017 , ... IndustryArchive.Org . is announcing a new way for ... will now only pay for B.A.N.T. quality sales leads based on the Sellers decision ... the new reality that B2B buyers are controlling the sales process via the Internet ...
(Date:2/26/2017)... Miami, Florida (PRWEB) , ... February 26, 2017 ... ... disease (PD) patients after receiving cognitive rehabilitation, according to a study released today ... already known that cognitive rehabilitation programs are proven to be effective in improving ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, ... Go. Core benefits and advantages built into the home office sit stand solution ... and feel. Ability to gain the benefits embedded in the TaskMate Go are ...
(Date:2/24/2017)... ... 24, 2017 , ... WHAT: , The New Jersey Tech ... well as advocacy for the state and region‘s technology businesses, hosted their 2017 ... Council's Innovation Forecast event highlights innovation throughout the region from small to large ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Smart Machine Age is here, and ... that 47 percent of all jobs in the United States may be taken over ... day of the aggressive know-it-all who steamrolls over colleagues is drawing to a close. ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
(Date:2/24/2017)... Wyoming , Feb. 24, 2017  Xynomic Pharmaceuticals, ... today announced that it has acquired exclusive worldwide ... potentially best-in-class innovative HDAC inhibitor targeting hematological and ... of 14 Phase 1 and 2 clinical trials ... Asia have already been completed, demonstrating ...
Breaking Medicine Technology: